Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Cleopatra Hospital Co's Other Operating Expense for the
three
months ended in Mar. 2026 was E£219 Mil.
Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was E£878 Mil.
Cleopatra Hospital Co's quarterly Other Operating Expense
increased
from Sep. 2025 (E£158 Mil) to Dec. 2025 (E£351 Mil) but then
declined
from Dec. 2025 (E£351 Mil) to Mar. 2026 (E£219 Mil).
Cleopatra Hospital Co's annual Other Operating Expense
increased
from Dec. 2023 (E£350 Mil) to Dec. 2024 (E£546 Mil) and
increased
from Dec. 2024 (E£546 Mil) to Dec. 2025 (E£812 Mil).
Cleopatra Hospital Co Other Operating Expense Related Terms
Cleopatra Hospital Co Other Operating Expense Historical Data
* Premium members only.
The historical data trend for Cleopatra Hospital Co's Other Operating Expense can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cleopatra Hospital Co Other Operating Expense Chart
Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)
Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.
Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was E£878 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Other Operating Expense of E£878 Mil mean?
Cleopatra Hospital Co (CAI:CLHO) has a Other Operating Expense of E£878 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Cleopatra Hospital Co and its competitors.
Is Cleopatra Hospital Co's Other Operating Expense too high?
Cleopatra Hospital Co's current Other Operating Expense is E£878 Mil. Overall, Cleopatra Hospital Co has a GF Score™ of 92/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cleopatra Hospital Co's Other Operating Expense compare to HCA and THC?
Cleopatra Hospital Co's Other Operating Expense of E£878 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Healthcare Providers & Services company?
A good Other Operating Expense depends on the Healthcare Providers & Services industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Cleopatra Hospital Co and its competitors. Cleopatra Hospital Co's current Other Operating Expense is E£878 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cleopatra Hospital Co stock overvalued right now?
Based on GuruFocus' analysis, Cleopatra Hospital Co (CAI:CLHO) is currently considered Modestly Overvalued. The stock's GF Value™ is E£14.18, compared to a current price of E£16.67 — trading 17.6% above its estimated fair value. The current Other Operating Expense is E£878 Mil. Cleopatra Hospital Co's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Cleopatra Hospital Co (CAI:CLHO), the current Other Operating Expense is E£878 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cleopatra Hospital Co (CAI:CLHO) Overvalued in 2026?
Based on GuruFocus' analysis, Cleopatra Hospital Co stock appears to be overvalued.
The current stock price of E£16.67 is trading 17.6% above its estimated GF Value™ of E£14.18.
GuruFocus considers Cleopatra Hospital Co to be Modestly Overvalued.
Key valuation signals for CAI:CLHO:
Other Operating Expense: E£878 Mil
GF Value™: E£14.18 vs. price of E£16.67 (17.6% above fair value)
No single metric tells the full story. See the CAI:CLHO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cleopatra Hospital Co establishes a private hospital to provide modern health and medical services, in addition to medical care for inpatients. The company's segments include Cleopatra Hospital Company, Cairo Specialised Hospital, Nile Badrawy Hospital, Al Shrouk Hospital, CHG Medical Services, CHG Pharma for Pharmacy Management, CHG for Hospitals Company, Queens Hospital, ElKateb Hospital, Bedaya El Gedida Company for Medical Centers and Hospitals, CHG SKY Hospital, and Cleopatra Heaven.
92GF Score
Get the complete analysis for CAI:CLHO
Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:CLHO has been successfully added to your 
